La catena delle opzioni mostra i dati chiave delle opzioni azionarie di ATI Physical Therapy a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per ATI Physical Therapy..

ATI Physical Therapy (NYSE:ATIP) Azioni, Catena delle Opzioni

ATI Physical Therapy

ATI Physical Therapy Inc is a recognized outpatient physical therapy provider in the United States specializing in outpatient rehabilitation and adjacent healthcare services. It offer a variety of services within the clinics, including physical therapy to treat spine, shoulder, knee and neck injuries or pain; work injury rehabilitation services, including work conditioning and work hardening; hand therapy; and other specialized treatment services.

ATI Physical Therapy, Inc. Class A Common Stock

ATI Physical Therapy Inc

ATI Physical Therapy Inc Warrants (10/08/2027)

Scotiabank analyst Nicholas Yulico maintains Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) with a Sector Outperform and raises the price target from $133 to $142.

News

Price Target

Analyst Ratings

WELL

Scotiabank Maintains Sector Outperform on Welltower, Raises Price Target to $142

Scotiabank analyst Tanya Jakusconek maintains Barrick Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) with a Sector Outperform and lowers the price target from $24 to $23.

GOLD

Scotiabank Maintains Sector Outperform on Barrick Gold, Lowers Price Target to $23

Scotiabank analyst Greg Harrison maintains BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Sector Outperform and raises the price target from $45 to $48.

BBIO

Scotiabank Maintains Sector Outperform on BridgeBio Pharma, Raises Price Target to $48

Scotiabank analyst Eric Winmill maintains Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) with a Sector Outperform and lowers the price target from $2.5 to $2.25.

GROY

Scotiabank Maintains Sector Outperform on Gold Royalty, Lowers Price Target to $2.25

Scotiabank analyst Ben Isaacson maintains Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) with a Sector Outperform and lowers the price target from $60 to $50.

Scotiabank Maintains Sector Outperform on Sociedad Quimica Y Minera, Lowers Price Target to $50

Formula 1 is expanding with an 11th team joining the global motorsport for the 2026 season, naming General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) <a href="https://www.benzinga.com/24/11/42135392/general-motors-gears-up-for-potential-f1-entry-in-2026-report">with Andretti Global.</a>
While the new team is still over a year away from starting, it will add an increased American presence to the sport and more competition for recent and four-time consecutive champion <a href="https://www.benzinga.com/general/education/21/12/24561188/max-verstappen-claims-his-first-f1-world-championship-5-things-you-might-not-know-about-the-for">Max Verstappen.</a>
What Happened: Formula 1, which is a unit of publicly traded Liberty Formula One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>), announced it reached an agreement with General Motors for a new team, branded as Cadillac, which will enter beginning in 2026, following up a previous rejection of a GM-linked team <a href="https://www.benzinga.com/general/entertainment/24/01/36875148/formula-one-rejects-andretti-general-motors-team-bid-what-this-could-mean-for-us-growth-esp">earlier this year.</a>
General Motors will also become an engine supplier for the league at a later date, the league <a href="https://www.formula1.com/en/latest/article/statement-on-general-motors-application-to-join-fia-formula-one-world.69uoRF1uwHwXkr4efkpnhc">announced</a>. The GM team will use Ferrari engines until the GM engines are officially approved for the sport.
"With Formula 1's continued growth plans in the U.S., we have always believed that welcoming an impressive U.S. brand like GM/Cadillac to the grid and GM as a future power unit supplier could bring additional value and interest to the sport," Liberty Media CEO Greg Maffei said.
General Motors President Mark Reuss called Formula 1 the "pinnacle of motorsports" and said the announcement of becoming the 11th team is an honor for the automotive company.
"We're committed to competing with passion and integrity to elevate the sport for race fans around the world," Reuss said. "This is a global stage for us to demonstrate GM's engineering expertise and technology leadership at an entirely new level."
The approval of the team comes after the U.S. Justice Department launched an investigation into why Liberty Media, who owns the commercial rights to Formula 1, would not approve the American team bid started by Michael Andretti.
The new team, called Cadillac F1, will be run by Andretti Global majority owners Dan Towriss and Mark Walter after Andretti stepped aside from the group in September. Former Formula 1 champion and racing legend Mario Andretti will have an ambassador role with Cadillac F1 while his son Michael will have no official position.
Read Also: <a href="https://www.benzinga.com/general/entertainment/23/12/36222143/netflix-lands-more-live-sports-how-success-of-docuseries-helped-pave-the-way">Netflix Lands More Live Sports: How Success Of Docuseries Helped Pave The Way</a>
Why It's Important: The announcement comes after Formula 1's Las Vegas Grand Prix, one of three U.S. races in 2024, was recently held and saw Max Verstappen <a href="https://www.espn.com/f1/story/_/id/42520866/max-verstappen-wins-fourth-f1-world-title-las-vegas-red-bull">win </a>his fourth consecutive Formula 1 World Championship.
While Verstappen finished fifth in the race, he secured enough points to guarantee that no one could match his points total with two races left in the season. This marks the fourth consecutive title by Verstappen with his first title in 2021 a close one with<a href="https://www.benzinga.com/general/sports/24/02/36897433/f1-legend-lewis-hamilton-set-to-join-ferrari-likely-to-replace-sainz-in-major-team-shake-up"> racing legend Lewis Hamilton.</a>
Verstappen has been dominant in the sport in recent years winning the title with races still left in season three of the four years. Verstappen won seven of the first 10 races this season before falling out of form but later did enough to win enough points to secure the title.
The new GM team marks the second American-owned team. Gene Haas owns a team but chooses to have international drivers. Michael Andretti's original vision was to have an American-owned team and also feature American drivers, something that fans of the sport will be closely watching.
Team expansion has been infrequent with four teams added in 2010 to push the total to 13 teams and 26 cars. Of the four teams added, one never raced and the other three were out of the league by 2017, as <a href="https://apnews.com/article/f1-grid-expansion-11th-team-andretti-9ffab2a3b1c71d59bd838b1c154b690f?taid=6744c0a5988d9800014d4a8b&amp;utm_campaign=TrueAnthem&amp;utm_medium=AP&amp;utm_source=Twitter">reported </a>by the Associated Press. &nbsp;
The existing 10 team owners have been against expansion due to the dilution of prize money, but have no formal say in the approval process.
Adding another American team could benefit ESPN, which is a unit of Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>). ESPN secured the renewal of the U.S. rights in 2022, paying an estimated $75 million to $90 million annually for the rights for three additional years.
ESPN fought off several other parties interested in the rights, as viewership for the sport has surged in recent years.
Along with recent growth in viewership in the U.S. Formula One teams have also experienced increased interest in ownership stakes from investors, including several notable American football players.
The Alpine racing team received&nbsp;<a href="https://www.formula1.com/en/latest/article.patrick-mahomes-travis-kelce-anthony-joshua-and-rory-mcilroy-among-host-of.3J4ua82zLZnEDJuM5Cegpe.html" target="_blank" rel="noreferrer noopener">investments&nbsp;</a>in 2023 from Kansas City Chiefs players&nbsp;Patrick Mahomes&nbsp;and&nbsp;Travis Kelce, professional golfer&nbsp;Rory McIlroy&nbsp;and actor&nbsp;Ryan Reynolds.
FWONA Price Action: Liberty Formula One shares were up 4.25% to $80.74 on Monday, hitting an intraday high of $80.88, which is a new 52-week high. The stock is up 41% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/41099414/ryan-reynolds-has-built-multiple-billion-dollar-brands-will-marketing-company-named-after-d">Ryan Reynolds&#8217; Billion-Dollar Streak: Will His Viral Marketing Firm Go Public Next?</a></li>
</ul>
Photo: Jay Hirano Photography via Shutterstock

Sports

Movers

Trading Ideas

FWONA

FWONK

Formula 1 Stock Hits 52-Week High, Announces 11th Team With General Motors/Andretti Global After Max Verstappen's Fourth Straight Title

SNBR

Sleep Number Issues Response To Public Letter To Shareholders From Stadium Capital Management; Reiterates That Its Highest Priority Is Identifying And Recruiting Optimal CEO Candidate

Scotiabank analyst Meny Grauman maintains Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) with a Sector Outperform and raises the price target from C$112 to C$147.

TSX:BMO

Scotiabank Maintains Sector Outperform on Bank of Montreal, Raises Price Target to C$147

The Company expects the Restated Financial Statements to reflect the following approximate impacts: as of December 31, 2023, (i) an increase in assets of $190 million, (ii) an increase in accrued expenses and other liabilities of $783 million, and (iii) a decrease in retained earnings of $593 million.&nbsp;
For the years ended December 31, 2023 and 2022, pre-tax income would be reduced by approximately $190 million to $3,636 million and $77 million to $5,641 million, respectively. For the third quarter of 2024, pre-tax income would decrease by approximately $6 million to $1,282 million while pre-tax income for the nine months ended September 30, 2024 would increase by approximately $700 million to $4,462 million (as compared to the pre-tax income reported in the financial information with respect to the quarter ended September 30, 2024 in the exhibits furnished with the Company's Current Report on Form 8-K filed with the SEC on October 16, 2024).

Discover Financial Services Gets NYSE Notice Regarding Filing Of Form 10-Q; Plans To Restate Certain Prior Period Financial Statements

Scotiabank analyst Meny Grauman maintains Canadian Imperial Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CM#TSX">CM</a>) with a Sector Outperform and raises the price target from C$85 to C$108.

TSX:CM

Scotiabank Maintains Sector Outperform on Canadian Imperial Bank, Raises Price Target to C$108

Guidance

LexinFintech Says Cautious About Short-term Economic Outlook And Anticipate Recently Released Government Stimulus Measures Targeting Economic Recovery To Gradually Take Effect

Dividends

LexinFintech Board Approves Amended Dividend Payout Policy, Increasing Payout Ratio To 25% Of Net Profit Starting In 2025

Scotiabank analyst Meny Grauman maintains Royal Bank of Canada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RY#TSX">RY</a>) with a Sector Outperform and raises the price target from C$167 to C$197.

TSX:RY

Scotiabank Maintains Sector Outperform on Royal Bank of Canada, Raises Price Target to C$197

LexinFintech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) reported quarterly earnings of $0.28 per share. The company reported $521.85 in sales this quarter. This is a 100.00 percent decrease over sales of $480.94 million the same period last year.

Earnings

LexinFintech Holdings Q3 2024 Adj EPS $0.28, Sales $521.85M

Scotiabank analyst Meny Grauman maintains Toronto-Dominion Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TD#TSX">TD</a>) with a Sector Outperform and raises the price target from C$86 to C$98.

TSX:TD

Scotiabank Maintains Sector Outperform on Toronto-Dominion Bank, Raises Price Target to C$98

Flint, Michigan&#8217;s <a href="https://lightnupcannabis.com/">Light'N Up Cannabis Company</a> is helping local families in need celebrate Thanksgiving with its annual give away of 1,000 turkeys this past Saturday.
"Once you get something like this started, it takes on a life of its own and is more fun and more rewarding each year," said Light'N Up founder Kyle Cohee.
"We've been through some tough times here in Flint, and people deserve every single break we can provide," he said. "Giving them the central part of a Thanksgiving meal is our honor and our way of thanking the people of Flint for supporting our store."
The veteran-owned business set aside 300 of the 1,308 turkeys for Vet Life, a local nonprofit serving veterans. Another eight turkeys went to the North End Soup Kitchen and area churches to help others in need.
Country music artist and veteran advocate Stephen Cochran joined the event, adding to the day's community spirit.
See Also: <a href="https://www.benzinga.com/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation">Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation</a>
<h3 class="wp-block-heading">Cannabis-Infused Thanksgiving In Arizona</h3>
Meanwhile, in Arizona, Mint Café, the state's first and only canna-kitchen, is putting a unique twist on Thanksgiving dinner. 
According to WDRB, the dispensary is offering a selection of cannabis-infused dishes, including THC-infused gravy, cranberry sauce, garlic herb butter and cornbread. For dessert, customers can choose between pumpkin and pecan pies, also infused with THC.
These special menu items will be available to adults 21 and older, providing an alternative way to enjoy a Thanksgiving feast.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/41843473/how-to-microdose-cannabis-for-a-stress-free-holiday-season-tips-for-newcomers">How To Microdose Cannabis For Stress-Free Holiday Season: Tips For Newcomers</a></li>
</ul>
Cover image made with AI.

Cannabis

Restaurants

1,000 Free Turkeys Donated By Michigan Dispensary, Cannabis-Infused Thanksgiving Feasts In Arizona

Citigroup analyst Michael Griffin maintains CBRE Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) with a Buy and raises the price target from $130 to $160.

CBRE

Citigroup Maintains Buy on CBRE Group, Raises Price Target to $160

Nuveen California Dividend Advantage Municipal Fund 2

Trading Halt: Halted at 5:53:28 p.m. ET - Trading Halt: Halt News Pending

The two lucky turkeys this year, Peach and Blossom from Minnesota, escaped the hatchet when President Joe Biden pardoned them in the annual pre-Thanksgiving tradition at the White House Monday.
&#8220;This event marks the official start of the holiday season here in Washington,&#8221; Biden <a href="https://abcnews.go.com/Politics/peach-blossom-continue-white-house-turkey-tradition/story?id=116182776">said</a> to a crowd of 2,500 gathered on the South Lawn. &#8220;It&#8217;s also my last time to speak here as your president during this season and give thanks and gratitude. So let me say to you, it&#8217;s been the honor of my life. I&#8217;m forever grateful.&#8221;
Read Also: <a href="https://www.benzinga.com/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation">Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation</a>
<h1 class="wp-block-heading">Don't Forget Those Others You Promised To Pardon</h1>
It's been over two years since&nbsp;<a href="https://www.benzinga.com/topic/joe-biden" target="_blank" rel="noreferrer noopener">Biden</a>&#8216;s announcement to pardon all prior federal offenses&nbsp;<a href="https://www.benzinga.com/markets/cannabis/22/10/29175510/breaking-biden-announces-pardons-for-all-federal-marijuana-possession-convictions" target="_blank" rel="noreferrer noopener">of simple marijuana possession</a>. It must be pointed out that not one single person among the approximately 3,000 people incarcerated for federal cannabis offenses has been released.
To remedy that situation, the&nbsp;<a href="https://www.benzinga.com/topic/last-prisoner-project" target="_blank" rel="noreferrer noopener">Last Prisoner Project</a>&nbsp;(LPP) has a great idea for the soon-to-be-retired president: release those prisoners immediately. 
In its People Not Poultry project, the LPP is calling on Biden to free the thousands of non-violent cannabis prisoners still incarcerated for offenses that are now legal in more than half the country. Last week, the LPP joined a chorus of advocates and over 60 Congress members in&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/11/42122853/67-lawmakers-urge-biden-to-grant-clemency-to-people-still-in-jail-for-cannabis-offenses">sending a letter</a>&nbsp;to Biden seeking clemency so families can be reunited for the holidays.
In a press conference on the capitol steps, LPP Director of Strategic Initiatives Jason Ortiz, said, "Sadly, as of today, President Biden has given freedom to more turkeys than he has to people [incarcerated for cannabis]. This is a gross injustice and an injustice that President Biden can correct with a stroke of a&nbsp;pen."&nbsp;
<h1 class="wp-block-heading">Think Of Your Legacy, President Biden</h1>
&#8220;But time is running out for President Biden to use this power effectively," LPP wrote in a press statement shared with Benzinga in October. &#8220;As President Biden approaches the final months of his presidency, he has the unique opportunity to correct the injustices of the War on Drugs that he once helped champion. By commuting the sentences of those still incarcerated for cannabis, he can take a bold stand for justice, equity and healing.&#8221;
Now Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42130001/green-wednesdays-biggest-weed-buyers-the-surprising-archetypes-driving-sales">Green Wednesday&#8217;s Biggest Weed Buyers: The Surprising Archetypes Driving Sales</a></li>
</ul>
Courtesy photo of National Turkey Federation with NTF chairman John Zimmerman and his son with President Joe Biden

Government

Legal

Joe Biden, How About Pardoning Non-Violent Cannabis Prisoners Along With Those Thanksgiving Turkeys?

Tigress Financial analyst Ivan Feinseth maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Buy and raises the price target from $96 to $103.

UBER

Tigress Financial Maintains Buy on Uber Technologies, Raises Price Target to $103

Finally, ATI Physical Therapy Within Striking Distance Of Profitability

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news to start the day with!



Moving stocks this morning a partnerships, a public offering, clinical trial news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Dermata Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/">DRMA</a>) stock is rocketing more than 123% alongside heavy pre-market trading.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) shares are soaring over 75% with strong early morning trading.</li>



<li>Hoth Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/hoth-stock-quote/">HOTH</a>) stock is surging more than 45% <a href="https://www.nasdaq.com/press-release/hoth-therapeutics-partners-lts-therapy-systems-accelerate-novel-alzheimers-treatment">on a new partnership</a> to develop its Alzheimer&rsquo;s treatment.</li>



<li>Allarity Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) shares are increasing over 44% after encouraging investors to <a href="https://finance.yahoo.com/news/allarity-encourages-shareholders-vote-reverse-100000785.html">vote for a reverse stock split</a>.</li>



<li>Regencell Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgc-stock-quote/">RGC</a>) stock is heading more than 33% higher alongside strong pre-market trading.</li>



<li>Pieris Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/pirs-stock-quote/">PIRS</a>) shares are rising over 28% after <a href="https://www.nasdaq.com/press-release/palvella-therapeutics-and-pieris-pharmaceuticals-announce-definitive-merger-agreement">announcing a merger agreement</a>.</li>



<li>Bone Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bblg-stock-quote/">BBLG</a>) stock is jumping more than 23% with heavy early morning trading today.</li>



<li>NewGenIvf (NASDAQ:<a href="https://investorplace.com/stock-quotes/nivf-stock-quote/">NIVF</a>) shares are climbing over 22% after providing a <a href="https://www.nasdaq.com/press-release/newgenivf-provides-update-potential-reverse-merger-covirix-2024-07-23">reverse merger update</a>.</li>



<li>Perfect Moment (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pmnt-stock-quote/">PMNT</a>) stock is getting a close to 19% boost after announcing a <a href="https://www.nasdaq.com/press-release/perfect-moment-teams-quiet-platforms-establish-distribution-center-us-2024-07-22">distribution center agreement</a>.</li>



<li>Catheter Precision (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vtak-stock-quote/">VTAK</a>) shares are up more than 16% without any clear news this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Azitra&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/aztr-stock-quote/">AZTR</a>) stock is crashing over 73% but only <a href="https://investorplace.com/2024/07/why-is-azitra-aztr-stock-up-315-today/">after a massive rally yesterday</a>.</li>



<li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) shares are plummeting 28% on <a href="https://www.12newsnow.com/article/news/local/texas/conns-reportedly-planning-mass-closures/502-4db60564-6fdd-4ffa-ae26-899bec91f75c">reports of impending store closures</a>.</li>



<li>ATI Physical Therapy (NYSE:<a href="https://investorplace.com/stock-quotes/atip-stock-quote/">ATIP</a>) stock is diving more than 25% without any obvious news this morning.</li>



<li>Verastem (NASDAQ:<a href="https://investorplace.com/stock-quotes/vstm-stock-quote/">VSTM</a>) shares are tumbling over 25% on a <a href="https://finance.yahoo.com/news/verastem-oncology-announces-proposed-public-200500583.html">proposed public offering</a>.</li>



<li>Agape ATP (NASDAQ:<a href="https://investorplace.com/stock-quotes/atpc-stock-quote/">ATPC</a>) stock is taking an almost 24% beating after a rally yesterday.</li>



<li>AtlasClear (NYSEMKT:<a href="https://investorplace.com/stock-quotes/atch-stock-quote/">ATCH</a>) shares are sliding more than 22% despite a lack of news on Wednesday.</li>



<li>Sage Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/sage-stock-quote/">SAGE</a>) stock is dropping over 22% after reporting <a href="https://www.nasdaq.com/press-release/sage-therapeutics-and-biogen-announce-topline-results-phase-2-kinetic-2-study-sage">Phase 2 topline results</a>.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) shares are decreasing more than 21% <a href="https://www.nasdaq.com/press-release/volato-updates-fractional-program-additional-differentiated-benefits-2024-07-23">after a recent rally</a>.</li>



<li>Chijet Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/cjet-stock-quote/">CJET</a>) stock is slipping over 19% following yesterday&rsquo;s rally.</li>



<li>Salarius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/slrx-stock-quote/">SLRX</a>) shares close out our pre-market stock movers down more than 19% after a rally yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-24th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

ATI Physical Therapy GAAP EPS of -$2.43 beats by $0.20, revenue of $188.11M misses by $1.89M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
ATI Physical Therapy (NYSE:<a href="https://investorplace.com/stock-quotes/atip-stock-quote/">ATIP</a>) just reported results for the second quarter of 2024.<ul><li>ATI Physical Therapy reported earnings per share of -$2.43. This was above the analyst estimate for EPS of -$2.63.</li><li>The company reported revenue of $188.11 million.</li><li>This was 0.99% worse than the analyst estimate for revenue of $190.00 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/atip-stock-earnings-ati-physical-therapy-for-q2-of-2024/">ATIP Stock Earnings: ATI Physical Therapy Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ATIP Stock Earnings: ATI Physical Therapy Beats EPS, Misses Revenue for Q2 2024

ATI Physical Therapy, Inc. (ATIP) Q2 2024 Earnings Call Transcript

In a report released today, Bill Sutherland from Benchmark Co. maintained a Hold rating on ATI Physical Therapy (ATIP – Research Report). The compa...

ATI Physical Therapy (ATIP) Gets a Hold from Benchmark Co.

ATI Physical Therapy, Inc. (ATIP) Q3 2024 Earnings Call Transcript

Ati Physical Therapy, Inc. ( ($ATIP) ) has released its Q3 earnings. Here is a breakdown of the information Ati Physical Therapy, Inc. presented to...

ATI Physical Therapy Q3 2024 Financial Performance and Outlook

14:29 EST ATI Physical Therapy (ATIP) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, marke...

ATI Physical Therapy trading halted, volatility trading pause

14:34 EST ATI Physical Therapy (ATIP) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...

ATI Physical Therapy trading resumes

ALLR

ATCH

ATIP

ATIPW

ATPC

AZTR

BBLG

CJET

CONN

DRMA

HOTH

NIVF

NUZE

OTRK

PIRS

PMNT

SAGE

SLRX

SOAR

VSTM

VTAK

Press Releases

TOM DENNINGER NAMED EXECUTIVE DIRECTOR OF THE INSTITUTE FOR MUSCULOSKELETAL ADVANCEMENT (iMSKA)

ATI Physical Therapy Reports First Quarter 2024 Results

ATI PHYSICAL THERAPY RECOGNIZED AS A GREAT PLACE TO WORK® FOR 2024

ATI Physical Therapy Provides Settlement Notice

Pomerantz LLP and Levi & Korsinsky, LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Fortress Value Acquisition Corp. II ("FVAC") or ATI Physical Therapy, Inc. Common Stock or Certain Holders of FVAC Common Stock

ATI Physical Therapy to Announce Second Quarter 2024 Financial Results

ATI Physical Therapy Reports Second Quarter 2024 Results

ATI Physical Therapy to Announce Third Quarter 2024 Financial Results

ATI Physical Therapy Reports Third Quarter 2024 Results

For 5th Consecutive Year, ATI Physical Therapy Achieves 'Exceptional' Rating In Patient Quality from the Center For Medicare and Medicaid Services (MIPS)

FAII

American Shared Hospital Services Common Stock

American Shared Hospital

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

CareMax

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Kindly MD

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

23andMe Holding

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Psychemedics

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

Comments

ATI Physical Therapy

ATI Physical Therapy (ATIP) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO